Not applicableStudy completedNCT03449745What this trial is testingImmune Checkpoint Receptors in AML-Leukemic Initiating CellsWho this might be right forAcute Myeloid Leukemia University Hospital, Bordeaux 199
Early research (Phase 1)Ended earlyNCT04614636What this trial is testingFT538 in Subjects With Advanced Hematologic MalignanciesWho this might be right forAcute Myeloid LeukemiaAML, AdultMultiple Myeloma+1 more Fate Therapeutics 42
Large-scale testing (Phase 3)WithdrawnNCT00411281What this trial is testingLow-Dose Cytarabine in Treating Infants With Down Syndrome and Transient Myeloproliferative DisorderWho this might be right forLeukemia Children's Oncology Group
Early research (Phase 1)Study completedNCT00003107What this trial is testingInterleukin-12 in Treating Patients With Hematologic Cancers or Solid TumorsWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more Indiana University
Early research (Phase 1)Study completedNCT00005092What this trial is testingChemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more M.D. Anderson Cancer Center 7
Early research (Phase 1)Active Not RecruitingNCT04623944What this trial is testingNKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDSWho this might be right forRelapsed/Refractory AMLAML, AdultMDS+1 more Nkarta, Inc. 61
Early research (Phase 1)Study completedNCT01433965What this trial is testingStudy of Lenalidomide in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic SyndromeWho this might be right forAcute Myeloid LeukemiaMyelodysplastic Syndrome University of California, Davis 16
Testing effectiveness (Phase 2)Study completedNCT01660607What this trial is testingPhase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T CellWho this might be right forMyeloid Leukemia, ChronicAcute Myelogenous LeukemiaMyelodysplastic Syndromes (MDS)+6 more Stanford University 68
Early research (Phase 1)Study completedNCT00530699What this trial is testingSafety, Tolerability and PK of AZD1152 in Patients With Relapsed Acute Myeloid Leukaemia (AML)Who this might be right forAcute Myeloid Leukaemia AstraZeneca 30
Early research (Phase 1)Study completedNCT01842139What this trial is testingVaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete RemissionWho this might be right forAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+4 more University of Chicago 7
Testing effectiveness (Phase 2)Looking for participantsNCT05580601What this trial is testingCytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML)Who this might be right forAcute Myeloid Leukemia Children's Hospital Medical Center, Cincinnati 20
Large-scale testing (Phase 3)Study completedNCT00260832What this trial is testingTrial of Decitabine in Patients With Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Eisai Inc. 485
Early research (Phase 1)Study completedNCT04714372What this trial is testingFT538 in Combination With Daratumumab in AML Acute Myeloid LeukemiaWho this might be right forAcute Myeloid LeukemiaMyeloid LeukemiaMonocytic Leukemia Masonic Cancer Center, University of Minnesota 9
Very early researchLooking for participantsNCT06398457What this trial is testingDarzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific AntibodiesWho this might be right forHematologic MalignancyBone Marrow Transplant RejectionAcute Myeloid Leukemia (AML)+9 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Not applicableUnknownNCT03450512What this trial is testingIncidence of Neutropenic Enterocolitis Study in Acute Myeloid Leukemia Patients During Intensive TherapyWho this might be right forAcute Myeloid Leukemia Centre Hospitalier Universitaire, Amiens 170
Testing effectiveness (Phase 2)Ended earlyNCT02418000What this trial is testingE6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 and/or Ras MutationsWho this might be right forAMLMDSCMML Spirita Oncology, LLC 27
Not applicableLooking for participantsNCT06782971What this trial is testingEvaluation of Combined Sensitising and Hypomethylating Therapy Outcomes in AML PDXWho this might be right forAML - Acute Myeloid Leukemia Clinical Hub for Interventional Research (CHOIR) 25
Early research (Phase 1)Study completedNCT03358719What this trial is testingDEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid LeukemiaWho this might be right forAcute Myeloid LeukemiaBlasts 30 Percent or Less of Bone Marrow Nucleated CellsChronic Myelomonocytic Leukemia+3 more Roswell Park Cancer Institute 8
Not applicableUnknownNCT01106144What this trial is testingGenetic Predictive Model Based on Single Nucleotide Polymorphisms in the DNA Repair Pathway and Drug Metabolis/Transport Pharmacogenetics in the Prediction of Response and Treatment Outcomes in Acute Myeloid LeukemiaWho this might be right forPatients With Acute Myeloid LeukemiaPatients Receiving Induction/Consolidation Chemotherapy Samsung Medical Center 500
Not applicableStudy completedNCT00899652What this trial is testingDNA Analysis of Bone Marrow and Blood Samples From Young Patients With Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaWho this might be right forLeukemia Children's Oncology Group 149